Targeted Therapeutic Drug Candidates for Cancer
XCOVERY
ALK, cancer, cMET, mTORC, PDGFR, PI3K, VEGFR, XVIVO
“XVIVO’s professional team met the many challenges posed by a pre-launch product and rendered visually compelling, high quality animations.” Vice President, Management Supervisor, Ogilvy Healthworld Medical Education
PDL BioPharma asked XVIVO to show how a novel humanized antibody, HuLuc 63, appears to induce anti-tumor effects by bind ... Read More
Biotechnology company Dendreon Corporation, has developed what is believed to be a method for getting around prostate ... Read More
... Read More